Related Experiment Videos
[Cryptogenetic liver cirrhosis with hypobetalipoproteinemia. Typing of the HLA histocompatibility system]
1Divisione Medicina Generale, USL n. 3 Carnica, Ospedale Civile, Tolmezzo, Udine.
Insights
This study identifies a unique subgroup of 15 patients with liver cirrhosis, characterized by low triglycerides and low beta-lipoprotein. The findings suggest a potential genetic link, possibly involving the HLA system, for this specific liver disease presentation.
Area of Science:
- Hepatology
- Clinical Biochemistry
- Immunogenetics
Background:
- Chronic liver disease encompasses various etiologies, with cryptogenetic liver cirrhosis representing cases of unknown origin.
- Hypotriglyceridemia and hypobetalipoproteinemia are lipid abnormalities that can be associated with various medical conditions.
- The Human Leukocyte Antigen (HLA) system plays a crucial role in immune responses and has been implicated in various autoimmune and chronic diseases.
Purpose of the Study:
- To investigate a specific clinical presentation of cryptogenetic liver cirrhosis associated with lipid abnormalities.
- To explore the potential pathogenetic mechanisms, including genetic factors, underlying this association.
- To determine if patients with this syndrome represent a distinct subgroup within the broader population of liver cirrhosis patients.
Main Methods:
- Study population: 146 patients with chronic liver disease.
- Subgroup identification: 15 patients exhibiting cryptogenetic liver cirrhosis, hypotriglyceridemia, and hypobetalipoproteinemia.
- Clinical assessment: Evaluation for compensated cirrhosis, absence of alcohol abuse, no major past illnesses, and no signs of portosystemic encephalopathy.
- Genetic analysis: HLA system typing, specifically focusing on the A2 antigen frequency.
Main Results:
- Fifteen patients presented with cryptogenetic liver cirrhosis, hypotriglyceridemia, and hypobetalipoproteinemia.
- These patients had compensated cirrhosis, no history of alcohol abuse, and no signs of portosystemic encephalopathy.
- A high frequency of the A2 antigen within the HLA system was observed in this patient subgroup.
Conclusions:
- The co-occurrence of cryptogenetic liver cirrhosis with hypotriglyceridemia and hypobetalipoproteinemia suggests a specific clinical entity.
- The high prevalence of the HLA A2 antigen indicates a potential genetic predisposition or association.
- These findings support the hypothesis that patients with this syndrome may constitute a particular subgroup of liver cirrhosis.
Abstract:
One hundred and forty-six patients with chronic liver disease have been studied. Some of them (15) showed a clinical picture characterized by cryptogenetic liver cirrhosis associated with hypotriglyceridemia and hypobetalipoproteinemia. These patients had compensated cirrhosis and no history of alcohol abuse; they did not suffer major illness in the past and had no signs of portosystemic encephalopathy. The pathogenetic mechanism of this association and the possible role of genetic factors are discussed. The HLA system has been studied and the A2 antigen found with high frequency, raising the possibility that patients with this syndrome may represent a particular subgroup among these with liver cirrhosis.